期刊文献+

人脐带间充质干细胞治疗环磷酰胺导致的大鼠药物性肝损伤 被引量:3

Human umbilical cord mesenchymal stem cells alleviate cyclophosphamide-induced liver injury in rats
下载PDF
导出
摘要 目的研究脐带间充质干细胞(umbilical cord-mesenchyma stem cell,UC-MSC)对环磷酰胺(cyclophosphamide,CTX)导致的大鼠药物性肝损伤的治疗作用.方法首先分离培养UC-MSC.SD大鼠腹腔注射CTX建立肝损伤模型,分别给予尾静脉注射UC-MSC或生理盐水,将其分为Control组、C TX组和CTX+UC-MSC组.在不同时间点检测血清谷丙转氨酶(alanine transaminase,ALT)、谷草转氨酶(aspartate transaminase,AST)、碱性磷酸酶(alkaline phosphatase,ALP)和总胆红素(total bilirubin,TBIL)的浓度.肝组织均浆中检测丙二醛(malondialdehyde,MDA)、脂质过氧化物(lipid peroxide,LPO)、一氧化氮(NO)、总超氧化物歧化酶(total superoxide dismutase,T-SOD)、谷胱甘肽(glutathione,GSH)、谷胱甘肽过氧化物(glutathione peroxidase,GSH-PX)的水平.qPCR检测肝组织中Bax、Bcl-2、血管内皮细胞生长因子(vascular endothelial growth factor,V E G F)A基因m R N A表达情况.肝组织切片行H E染色和α-平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)、Ki-67染色.结果与Control组相比,CTX组ALT、AST、ALP和TBIL含量明显增高,SOD、GSH和GSH-PX表达下降,MDA、LPO和NO表达增加,凋亡增加,VEGFA表达减少,肝细胞水肿明显.CTX+UC-MSC组ALT、AST、ALP和TBIL值均低于CTX组(P<0.05).CTX+UC-MSC组的SOD、GSH和GSH-PX均高于CTX组,MDA、LPO和NO均低于CTX组(P<0.05).CTX+UC-MSC组的Bax的表达低于CTX组,BCL-2和VEGFA的m RNA水平高于CTX组(P<0.05).HE染色示CTX+UC-MSC组的肝细胞水肿、出血等损伤低于CTX组.CTX+UC-MSC组的α-SMA^+细胞少于CTX组,Ki-67^+细胞多于CTX组(P<0.05).结论 UC-MSC治疗可缓解CTX导致的大鼠药物性肝损伤. AIM To assess the effect of human umbilical cord mesenchymal stem cells(UC-MSCs) on cyclophosphamide(CTX)-induced liver injury.METHODS UC-MSCs were isolated from the human umbilical cord. Male SD rats were randomly divided into three groups: control group, CTX group, and CTX + UCMSC group. The CTX group and CTX + UC-MSC group were intraperitoneally injected with CTX. After that, the control group and CTX group were injected with water via the tail vein, and the CTX + UCMSC group was injected with MSCs via the tail vein. Six rats of each group were selected randomly and sacrificed at different time points. Blood samples were taken to measure serum alanine transaminase(ALT), aspartate transaminase(AST), alkaline phosphatase(ALP), and total bilirubin(TBIL). Liver tissues were collected for biochemical assays of malondialdehyde(MDA),lipidperoxide(LPO),NO,glutathione(GSH), glutathione peroxidase(GSH-PX), and total superoxide dismutase(T-SOD). q PCR was used to test the expression of Bcl-2, Bax, and vascular endothelial growth factor(VEGF) A. Histological examination(HE straining) and immunohistochemical staining for α-smooth muscle actin(α-SMA) and Ki-67 were also performed.RESULTS Compared with the control group, the levels of ALT, AST, ALP, and TBIL were significantly higher, the SOD, GSH, and GSH-PX contents were significantly lower,MDA,LPO,and NO were significantly higher, cell apoptosis significantly increased, and the expression of VEGFA significantly decreased in the CTX group. Compared with the CTX group, the ALT, AST, ALP, and TBIL were significantly lower, the SOD, GSH, and GSH-PX contents were significantly higher, and MDA, LPO, and NO were significantly lower in the CTX + UC-MSC group(P 0.05). The expression of Bax was lower and Bcl-2 and VEGFA expression was higher in the CTX + UC-MSC group than in the CTX group(P 0.05). Pathological analysis showed that liver status was better in the CTX + UC-MSC group than in the CTX group. The α-SMA~+ cells in the CTX + UC-MSC group were less than and Ki-67~+ cells were more than those in the CTX group(P 0.05). CONCLUSION UC-MSCs injected via the tail vein could alleviate CTXinduced hepatotoxicity in rats.
出处 《世界华人消化杂志》 CAS 2017年第33期2956-2966,共11页 World Chinese Journal of Digestology
基金 山东大学基本科研资助项目 No.2014QLKY02 山东省自然科学基金资助项目 Nos.ZR2015HM053 ZR2014HP053 国家自然科学基金资助项目 No.81473484~~
关键词 脐带间充质干细胞 环磷酰胺 药物性肝损伤 细胞治疗 Umbilical cord-mesenchyma stem cells Cyclophosphamide Liver injury Cell therapy
  • 相关文献

参考文献5

二级参考文献133

  • 1翁山耕,冷希圣,魏玉华,彭吉润,张佑彬,吕建锋,杜如昱.白细胞介素10抑制枯否细胞诱导的肝星状细胞激活的研究[J].中华医学杂志,2002,82(2):104-107. 被引量:19
  • 2赵东长,陈蕊,余伟华,雷俊霞,彭延文,刘宇,张秀明,李树浓,项鹏.骨髓间质干细胞抑制肝星状细胞增殖与活化的体外研究[J].中国病理生理杂志,2005,21(6):1139-1142. 被引量:16
  • 3穆丽雅,韩明子.骨髓干细胞分化为肝细胞的多种移植途径[J].世界华人消化杂志,2006,14(6):607-610. 被引量:5
  • 4Elsharkawy AM, Oakley F, Mann DA, et al. The role and regulation of hepatic stellate cel{ apoptosis in reversal of liver fibrosis[J]. Apoptosis, 2005,10(5): 927-939.
  • 5am Esch JS 2nd, Knoefel WT, Gbodsizad A, et al. Portal application of autologous CD133^+ bone marrow cells to the liver: a novel concept to support hepatic regeneration [ J ]. Stem Cells, 2005, 23(4) : 463 -470.
  • 6Sung JH, Yang HM, Park JB, et al. Isolation and characterization of mouse mesenchymal stem cells [ J ]. Transplant Proc, 2008, 40 (8) : 2649 - 2654.
  • 7Sakaida I, Terai S, Yamamoto N, et al. Transplantation of bone marrow cells reduces CC14-induced liver fibrosis in mice[J]. Hepatology, 2004, 40(6) : 1304- 1311.
  • 8Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis[J]. Arch Iranian Med, 2007, 10(4) : 459 - 466.
  • 9Parekkadan B, van Poll D, Megeed Z, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem ceils [ J ]. Biochem Biophys Res Commun, 2007, 363 (2) : 247 -252.
  • 10Kim JY, Kim KM, Nan JX, et al. Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells [ J ]. Pharmacol Toxicol, 2003, 92 (4) : 195 - 200.

共引文献31

同被引文献38

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部